Repligen Cp (RGEN)
$169.08
2.70 (1.57%)
RGEN Stock Quote Delayed 30 Minutes
RGEN Stock Earnings: Repligen Misses EPS, Beats Revenue for Q1 2024
RGEN stock results show that Repligen missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
9.41B
PE Ratio
331.53
EPS
0.51
Volume (Avg. Vol.)
47,322
Day's Range
$168.85 - $171.75
52-Week Range
$110.45 - $211.13
Dividend & Yield
N/A (N/A)
RGEN Stock Predictions, Articles, and Repligen Cp News
3 Great Growth Stocks That Kept Climbing in This Tough Market
While many companies were unable to avoid the wrath of the coronavirus pandemic, these three companies stood out as big winners.
Repligen Stock Could See Significant Upside With Coming ETF Realignment
Smart beta ETFs typically rebalance every 90 days. The next big rebalance will come in the next few weeks and likely push healthcare stock Repligen (RGEN) higher.
3 Biotech Stocks That Show The Good, The Bad and the Ugly Side of This Sector
When rumors start buzzing that the government may be about to intervene, then biotech stocks often get slammed...some fairly, and some not (as we’ll see).
This Medical Device Company is Outperforming the Rest of the Sector
This morning, I am recommending a bullish trade on Repligen Corporation (NASDAQ:RGEN), the bioprocessing company.
Trade of the Day: Repligen (NASDAQ:RGEN)
Investors are in for a wild ride later this week as Under Armour prepares to report its first-quarter earnings results before the open on Thursday.
37 Biotechnology Stocks to Sell Now
This week, the overall grades of 37 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Hottest Manufacturing Stocks Now – RDUS ATRA RARE CMCO
The following stocks were moving the Manufacturing sector today.
21 Biotechnology Stocks to Buy Now
This week, 21 Biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
19 Biotechnology Stocks to Sell Now
This week, the ratings of 19 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Hottest Manufacturing Stocks Now – PERY RAVN MLSS ALG
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
Biggest Movers in Healthcare Stocks Now – LXRX CEMP LGND ANAC
Healthcare stocks rose broadly on Wall Street on Thursday morning, with the sector seeing an overall increase of 0.3%.
Biggest Movers in Healthcare Stocks Now – SGEN NKTR IRWD IMGN
Healthcare stocks rose broadly on Wall Street on Friday, with the sector seeing an overall increase of 0.6%.
Biggest Movers in Healthcare Stocks Now – MDCO THRX ALNY FOLD
Healthcare stocks remained flat on Monday morning on Wall Street.
Hottest Healthcare Stocks Now – LUX PBYI ALNY MRK
Healthcare stocks advanced broadly on Wall Street on Wednesday morning, with the sector seeing an overall increase of 2.5%.
Hottest Healthcare Stocks Now – LUX MNKD CLDX LCI
Healthcare stocks fell on Wall Street on Thursday morning, down 0.3%.
